Effect of Aldose Reductase Inhibition on Resistance to Ischemic Conduction Block in Diabetic Subjects

Abstract

Aldose reductase inhibition with ponalrestat partly reverses RICB in diabetes, perhaps by improving nerve hypoxia or reducing nerve energy substrates.